Aigen Sciences

Private

SeoulHealthcare & Life Scienceshttps://aigensciences.com/

Last Round

Series A

Oct 16, 2024

Total Funding Raised

$11.74M

Company Overview

Aigen Sciences is a biotechnology company that provides an AI-driven drug discovery platform to develop small-molecule synthetic drugs for intractable diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

drug discoveryAI drug discoverysmall-molecule therapeuticsgenerative AItranscriptome dataoncology researchlarge language modelsLLMin silico drug designADMET modelingbiotech R&Dprecision medicineAI-first biotechdrug pipelinecomputational biology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aigen Sciences Comps

Public and private peers based on sector, stage, and business model.

Aigen Sciences comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Aigen Sciences Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Oct 16, 2024
Pre Seed	Oct 5, 2022

View all Funding Rounds

Aigen Sciences Investors

Notable investors and investment history

Aigen Sciences investors
Investor	Rounds
Korea University Holdings	Pre Seed
K2 Investment Partners	Series A
Bluepoint Partners	Pre Seed
Premier Partners	Series A
QUAD Investment Management	Series A
Medytox Venture Investment	Pre Seed, Series A
Partners Investment	Pre Seed, Series A

View all Investors

Aigen Sciences Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Aigen Sciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Aigen Sciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul

Employee Range14

Year Founded2021

Last FundingOct 16, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.